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Abstract: Objective To improve discharge prescription quality and information transfer to improve post-
hospital care with a pragmatic in-hospital service. Design A single-centre, randomized controlled trial
Setting Internal medicine wards in a Swiss teaching hospital Participants Adult patients discharged to
their homes, 76 each in the intervention and control group. Intervention Medication reconciliation at
discharge by a clinical pharmacist, a prescription check for formal flaws, interactions and missing therapy
durations. Important information was annotated on the prescription. Main Outcome Measures : At
the time of medication dispensing, community pharmacy documented their pharmaceutical interventions
when filling the prescription. A Poisson regression model was used to compare the number of interven-
tions (primary outcome). The significance of the pharmaceutical interventions was categorized by the
study team. Comparative analysis was used for the significance of interventions (secondary outcome).
Results The community pharmacy staff performed 183 interventions in the control group, and 169 in the
intervention group. The regression model revealed a relative risk for an intervention of 0.78 (95% CI
0.62-0.99, p=0.04) in the intervention group. The rate of clinically significant interventions was lower in
the intervention group than in the control group (72 of 169 (42%) vs. 108 of 183 (59%), p<0.01), but
more economically significant interventions were performed (98, 58% vs. 80, 44%, p<0.01). Conclusions
The pragmatic in-hospital service increased the quality of prescriptions. The intervention group had a
lower risk for the need for pharmaceutical interventions, and clinically significant interventions were less
frequent. Overall, our pragmatic approach showed promising results to optimize post-discharge care.
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To improve discharge prescription quality and information transfer to improve post-hospital care with a 
pragmatic in-hospital service. 
Design 
A single-centre, randomized controlled trial 
Setting 
Internal medicine wards in a Swiss teaching hospital 
Participants 
Adult patients discharged to their homes, 76 each in the intervention and control group 
Intervention 
Medication reconciliation at discharge by a clinical pharmacist, a prescription check for formal flaws, 
interactions and missing therapy durations. Important information was annotated on the prescription. 
Main Outcome Measures 
At the time of medication dispensing, community pharmacy documented their pharmaceutical 
interventions when filling the prescription. A Poisson regression model was used to compare the number 
of interventions (primary outcome). The significance of the pharmaceutical interventions was categorized 
by the study team. Comparative analysis was used for the significance of interventions (secondary 
outcome). 
Results 
The community pharmacy staff performed 183 interventions in the control group, and 169 in the 
intervention group. The regression model revealed a relative risk for an intervention of 0.78 (95% CI 0.62-
0.99, p=0.04) in the intervention group. The rate of clinically significant interventions was lower in the 
intervention group than in the control group (72 of 169 (42%) vs. 108 of 183 (59%), p<0.01), but more 
economically significant interventions were performed (98, 58% vs. 80, 44%, p<0.01).  
Conclusions 
The pragmatic in-hospital service increased the quality of prescriptions. The intervention group had a 
lower risk for the need for pharmaceutical interventions, and clinically significant interventions were less 




Community pharmacists are often the first health care professionals encountered by the discharged 
patient [1]. Community pharmacists reported that dispensing to this population is important in terms of 
safety issues [2]. Drug related problems (DRPs), which affect 33-63.7% of discharged patients, can be 
identified by the community pharmacists [3-5]. Pharmaceutical interventions (PIs) may solve DRPs, but 
are often time-consuming [6, 7].  
Lack of information on prescriptions was shown to hinder the identification of DRPs [2, 3, 7]. Pharmacists 
in Switzerland, and in other countries, reported that this applies for many essential information items, and 
they called for complete and updated information [2, 8, 9]. These are, specifically complete medication 
lists, information on medication changes, interactions, or more detailed information about compounded 
medication. Furthermore, patient involvement and counselling in discharge is crucial, as the patients' 
knowledge about medication may be limited [10, 11]. 
Different services to overcome inefficient or limited information transfer to pharmacies have been 
described in the literature [12-14]. Examples of services are the provision of instructions for health care 
professionals [15], the employment of liaison pharmacists [4] or the development of an information 
transfer sheet for hospitals [9]. Many such explanatory studies use strict designs, introduce new processes 
or need extensive resources for their service, which may hinder later implementation [8, 16]. As Treeweek 
et al. illustrated, applicability of a service may be a crucial aspect for decision makers. In addition, it 
should be taken into account that a country may have limited clinical pharmacy resources, as is the case in 
Switzerland [17]. Pragmatic approaches using realistic resources and based on existing processes are 
easier to implement in practice.  
 
As clinical outcomes may be difficult to measure and depend highly on the patient’s health, process 
measures may be useful indicators for the success of a service [12]. These may be medication errors [18] 
or pharmacist satisfaction with the prescription [4]. Other possible outcomes could be process measures 
representing the dispensing activities by community pharmacists, like PIs [19]. The literature lacks 






We designed a pragmatic in-hospital service by a clinical pharmacist, focusing on a discharge prescription 
check, and transfer of discharge information to community pharmacies. The primary aim was to increase 
quality of discharge prescriptions in the intervention group, measured by a reduction of PIs at the 
community pharmacy. We aimed to reduce the workload when filling the prescription, measured by time 
needed for prescription filling in the pharmacy and by established contacts, and to increase the 
satisfaction of the community pharmacist with the prescriptions. Furthermore, readmission rates, and the 
feasibility of the service should be evaluated.  
Methods 
The study was a single-centre, randomised controlled trial conducted at a tertiary teaching hospital in 
Baden, Switzerland. The procedures were developed according to the Medical Research Council guidance 
[20]. Ethical approval was given by the ethics committee.  
 
Patient recruitment 
Three wards of the internal medicine department (specialisations A: stroke and respiratory diseases, B: 
infectious diseases, nephrology and cardiology, C: geriatric ward) took part in the study. Patient records 
were consecutively screened for eligible patients during 13 weeks from January to April 2017. Inclusion 
criteria were: Patients of the internal medicine department, ≥ 18 years, without isolation due to infection, 
with standard or semi-private insurance, without cognitive impairment (e.g. acute delirium or severe 
dementia) that hinders patients from giving consent. Exclusion criteria were: Insufficient hearing or 
speaking skills to give consent, no consent, no medication prescribed, discharge on weekends, or those not 
being discharged to their homes. Patients were also excluded if they planned to fill their prescription in a 
non-participating pharmacy. Pharmacies were recruited in advance at a meeting of the regional 
pharmacists’ association and also through a mailed request. All 121 pharmacies within the region were 
eligible, of which 70 participated. Eligible patients were visited in their hospital room and informed about 
the study by the investigators (LB, GP) in oral and written form. Patients gave written informed consent.  
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Study procedure  
Shortly before the discharge of enrolled patients, they were 1:1 block randomised by LB in groups of 10, 
by means of a computer-generated randomised list. Consecutive numbers were given to consecutively 
discharged patients. Demographic data were recorded. The prescription was prepared as usual by the 
resident physician in charge. In both groups, a label was added to prescriptions that allowed the 
community pharmacy to recognise study patients.  
In the intervention group, a clinical pharmacist (LB, CB) performed the service (exposure) and recorded 
the time needed. The service consisted of a prescription check, to identify DRPs, and a discussion of 
relevant PIs for optimisation, which were the following:  
- Medication reconciliation was performed with the medication list from admission and from the 
last hospitalisation day. The pharmacy staff was not involved at admission. Changes were clarified 
with the resident, mostly by phone. Unintentional changes were corrected and intentional 
changes were specified on the prescription (e.g. “new”, “stopped”, “changed dose”) 
- If opioids were prescribed on the normal prescription, the resident was informed that a special 
narcotic prescription form was needed.  
- Formal flaws in names or units, unlicensed or compounded medications were identified and 
clarified with the resident; flaws were corrected or specified on the prescription (e.g. 
“compounded medication”, “medication available in Germany”). 
- Missing therapy duration for anti-infectives and subcutaneous heparin was clarified with the 
resident and added to the prescription. 
- Drug-drug interactions of grades 1-3 (1: “contraindicated”, 2: "contraindicated for precaution" 3: 
“surveillance/adjustment”) according to the Pharmavista software were checked [21]. Relevant 
interactions according to the clinical pharmacist's expertise were discussed and solved with the 
resident. Acceptable interactions were commented on the prescription (“Interactions were 
checked and can be tolerated”). 
PIs accepted by the resident were implemented by the clinical pharmacist (LB, CB) directly on the usual 
prescription within the electronic patient records of the hospital. The resident then checked and signed 




At discharge, the resident handed out the prescription to the patient in both groups as usual. For all 
enrolled patients, a pharmacy case report form (pCRF) was faxed to the patient’s community pharmacy. 
Previous to the study start, a Youtube video training was provided explaining the study procedure and 
how to fill the case report form. A second video explained the pCRF with an example case. The videos did 
not inform in detail about the service, to limit reporting bias.  
 
The community pharmacies were blinded to the patient’s group allocation. When the patient filled the 
prescription at their preferred pharmacy, a pCRF was completed for each prescription. All PIs were 
documented on the pCRF and categorised by the staff using an adapted form of pharmDISC (categories C-
F), a validated classification system for community pharmacies [22]. The person contacted (e.g., 
physician) for discussion and resolution of the PI and their acceptance was documented on the pCRF by 
the pharmacies. For each prescription, the date, duration of prescription filling, the pharmacy staff’s job 
role and their satisfaction with the prescription was documented.  
 
The pCRF was then sent back to the study team. If no data was provided within some days after the 
patient’s discharge, the pharmacy was called to ask for data transmission, or to identify drop-outs. Drop-
outs were defined as patients who never filled their discharge prescription in the named or another 
participating pharmacy, or patients whose pharmacy did not provide data.  
 
Data entry and categorisation according to CLEOde [23] were done by blinded investigators at the hospital 
pharmacy (GP, PW). CLEOde is a validated tool to categorise the clinical, economical and organisational 
significance of a PI. If needed, they called the pharmacy to clarify documentation. All data was double-
checked by another blinded investigator (ML). Readmission rates were provided by the medical 
controlling unit, and were categorised as within 7, 18 and 30 days in accordance with the literature and 





The primary outcome was defined as the number of PIs performed in the community pharmacy. 
Secondary outcomes were the duration of prescription filling, established contacts for a PI, and pharmacy 
staff’s satisfaction with the prescription quality. Subjective satisfaction of prescription quality was 
documented on a 5-point Likert scale (very/rather satisfied, rather/very unsatisfied, not applicable). 
Furthermore, outcomes were the frequency pattern of performed PIs, the pharmacy staff’s job role (e.g., 
technician), the time to fill the prescription after discharge, and readmission rates. Feasibility of the 
service was evaluated by the time needed to perform it. 
 
For the primary outcome (the number of PIs) a Poisson regression model was fitted. Independent 
predictors were selected based on the literature [26-29] and discussion, and included gender, age, 
emergency admission, length of stay, number of medications, and the staff’s job role. In addition, 
prescriptions were categorised into two groups, (prescriptions with at least one PI and those with no PI) 
and a logistic regression model with the same predictors was fitted. 
 
Comparative statistical analysis was used to describe patient characteristics and outcomes in both groups. 
A Kruskal Wallis Test was applied to discrete and continuous variables (e.g. age, number of contacts, time 
needed to fill prescription), and a Fisher’s Exact Test was applied to categorical variables (e.g. sex, 
satisfaction, readmission rates).  
 
Calculations and analyses were performed using the software R, version 3.4.0 (R Foundation for Statistical 
Computing, Vienna, Austria). A two-sided p-value of <0.05 was considered as statistically significant. 
Power analysis based on the primary outcome with a level of significance α = 0.05 and a power of 1-β = 0.8 





Of 866 screened patients, 172 were included in the study (Figure 1). With 10 drop outs in each group, 
complete data sets were obtained for 152 patients (152 prescriptions). No statistically significant 
differences in their baseline characteristics were found (Table 1). The median duration of the in-hospital 
service by the clinical pharmacist, indicating feasibility, was 7 minutes [IQR 4, 9]. Community pharmacies 
performed 183 PIs for the 76 control group prescriptions, and 169 PIs for the 76 intervention group 
prescriptions. The Poisson regression analysis (Table 2) revealed that being allocated to the intervention 
group was an independent predictor for a lower number of PIs (relative risk 0.78 (CI 0.62-0.99), p=0.04). 
With increasing length of stay, the number of PIs decreased. Pharmacists filling the prescription instead of 
other staff, as well as increasing number of prescription items correlated with a higher number of PIs. In 
the logistic regression analysis (Table 2), being in the intervention group was also an independent 
predictor for having any PI (0.33 (CI 0.13-0.78), p=0.01)).  
 
Secondary outcomes are presented in Table 3. PIs with clinical significance measured by CLEOde 
significantly decreased in the intervention group, and those with an economic significance increased. 
There were significant differences between both groups in terms of contacts established for the 
clarification of a PI by the pharmacy staff and their satisfaction. However, no differences were found for 
the time needed to fill the prescription. Readmission rates did not differ between the groups (Table 3). In 
the Table 4, the patterns of performed PIs in the community pharmacy are shown.  
Discussion 
We conducted a randomised controlled trial with a pragmatic, 7 minute in-hospital discharge service 
performed by a clinical pharmacist. Being allocated to the intervention group was an independent 
predictor of lower number of PIs. Clinically significant PIs were significantly reduced in the intervention 
group. The number of different persons contacted to discuss the PIs did differ between the groups, and 
there were less hospital physicians contacted in the intervention group. Prescription filling was of equal 
duration in both groups. Satisfaction of the pharmacy staff with the quality of prescription was enhanced 




Overall, being allocated to the intervention group was a predictor for having less PIs, as was hypothesised 
based on similar services [30]. The effect was even stronger when prescriptions were categorised 
according to whether they needed no or any PI. A longer length of stay correlated with a lower PI rate. It 
can be hypothesised that with longer hospital stay, discharge prescriptions were more carefully prepared. 
The length of stay in Swiss acute care settings has decreased in recent years [31]. This may be due to new 
remuneration systems which make early discharges economically more attractive to hospitals. In the 
pharmacy, the most qualified staff (pharmacists) performed the higher number of PIs. This may not be 
generalizable to other countries, but a Swedish study showed similar trends [29].  
 
The rate of PIs per patient in the control group (median 2) was similar to a Swiss study in general 
pharmacy clients in the German speaking region (mean of 1.2 PIs) [32], but much lower than in a study 
from the French speaking region (mean 6.9 PIs) [30]. This second group studied older patients and had a 
study pharmacist facilitating PI documentation in the pharmacies. 
 
Secondary outcomes 
The PIs performed showed different beneficial significances in both study groups. Through the service, 
there was a high and significant effect on the clinical and economic significance of the PIs. There were 
significantly less PIs needed with any clinically beneficial significance in the intervention group. That can 
be interpreted as a quality indicator for the discharge prescription, which led less frequently to the 
identification of DRPs. On the other hand, significantly more economical PIs, which may reduce costs, 
were performed in the intervention group. This could be due to an increase of adaptation of package sizes 
to the annotated therapy duration. It can be assumed that the health care costs would be reduced, but this 
was out of the scope of this study and should be evaluated in a cost-effectiveness study.  
 
The number of contacts that were established between the community pharmacy staff and other health 
care professionals differed statistically significantly between the groups. There seemed to be fewer 
contacts to the hospital physicians. This would prevent physicians from being interrupted, possibly 
preventing errors, and reduce the need for costly resources. This shows that the studied in-hospital 
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services were useful, especially for hospital-related problems and questions that would usually be solved 
with a call to the hospital.  
 
Satisfaction of community pharmacists with discharge prescriptions was already high in the control group 
but was even higher in the intervention group. This is consistent with a prior discharge organisation trial 
at our study site [33]. It is possible that the satisfaction was not specifically influenced by the service itself, 
but through participation in the study.  
 
Drug-drug interactions triggered less PIs in the intervention group. There is an obvious correlation to the 
service, as interactions were clarified or annotated on the prescription as tolerable. There were more PIs 
in the intervention group related to therapy duration. This may be due to the enhanced communication of 
a specified therapy duration, which, for example, triggered more exact adaptions of package sizes. 
Clarifications were reduced in the intervention group, a task that was reported to be highly work-
intensive in a previous study [2]. We hypothesised that the time needed would be reduced in the 
intervention group, which was not the case. A reason may be, that documentation was mostly done in 
round numbers (e.g. 10 minutes) instead of the exact time and should therefore be interpreted with 
caution.  
 
The intervention did not significantly influence the readmission rates. But the rates in the control group 
were similar to countrywide data [31]. Overall, readmission rates may be influenced by hospital 
characteristics [34]. 
Strengths and Limitations 
A strength of our study is that we used a RCT design, in contrast to a previous before-after study showing 
a greater effect [30]. A pragmatic approach was chosen for the design of the service, as clinical pharmacy 
resources in our country have to be used efficiently [17]. The intervention needed only 7 minutes per 
patient to perform, which is much shorter than in other trials, and can be judged as feasible [30]. On one 
hand, pragmatic trials best reflect effectiveness in clinical practice, and it is thought this will support later 
implementation [16]. On the other hand, pragmatic services do not account for all DRPs and therefore may 
11 
 
have a lower impact on process measures and a patient’s health outcome. Overall, process measures are 
useful and widely used to detect the effectiveness of a service in transition of care [12]. 
It is not known how equally community pharmacists documented PIs or if they used best or common 
practice. One shortcoming of our study is the fact that community pharmacists were blinded to 
randomisation, but they may have detected differences in information content on prescriptions. 
Therefore, we cannot completely rule out that reporting in pCRFs has been influenced. Residents were 
informed about the study, and PIs to their patients' prescriptions could have led to higher quality of the 
following prescriptions.  
Topics chosen to be addressed in this RCT, such as medication changes and interactions were based on the 
findings of a previous study, where Swiss community pharmacists evaluated availability and usefulness of 
discharge information [2]. To increase the possibility of measuring the differences in readmissions, the 
study should have been powered for this outcome. The study was performed only at one study site. 
Generalisability could therefore be limited, but the international literature has studied similar topics [9, 
35]. Therefore, our findings may be generalizable to other regions or countries with a similar health care 
setting.  
Conclusion 
The results of our study suggest that a pragmatic, 7-minutes in-hospital service reduces the risk of 
prompting pharmaceutical interventions at post-hospital dispensing in community pharmacies. Thus, the 
service may improve hospital discharge prescription quality in an efficient and effective way. In a health 
care system with limited resources, the service might ultimately improve patient safety at transitions of 
care. 
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Table 1: Baseline characteristics and outcomes of the 152 enrolled patients (76 patients in the control group and 76 
patients in the intervention group). Fisher’s Exact Test was used for categorial variables, Kruskal-Wallis Test for 
continuous and discrete variables.  
 Control group (n=76) Intervention group (n=76) p 
Age, median [IQR] 71 [57, 79] 72 [61, 79] 0.46 
Male gender, n (%)  43 (56.6) 48 (63.2) 0.51 
Emergency admission, n (%)  57 (75.0) 63 (82.9) 0.32 
Hospitalisation ward, n (%) 
Ward A 
Ward B 
Ward C  
 
28 (36.8)  







Length of stay, median days [IQR] 7.00 [4.75, 10.00]   5.50 [4.00, 8.00] 0.51 




Table 2: Regression models:  Poisson regression analysis model for the primary outcome for the number of 
interventions, and logistic regression analysis model for the number of prescriptions with no or at least 1 
intervention, n=152, * = statistically significant, CI= Confidence interval 
 Poisson regression 
model for number of 
interventions 
 Logistic regression model for 
number of prescriptions with no or 
at least 1 intervention 
 
 Relative risk (95% CI) p Odds ratio (95% CI) p 
Intervention group  0.78 (0.62-0.99) 0.04* 0.33 (0.13- 0.78) 0.01* 
Emergency admission 0.80 (0.64-1.02) 0.07   0.56 ( 0.14-1.89) 0.37 
Male sex 0.96 (0.76-1.21) 0.73 0.39 (0.15-0.95) 0.04* 
Length of hospital stay 0.97 (0.95-0.99) <0.01*  0.86 (0.77-0.97) 0.01* 
Age 0.99 (0.99-1.00) 0.16 0.99 (0.96-1.02) 0.47 
Number of prescribed items 1.17 (1-14-1.20) <0.01* 1.39 (1.19-1.68) <0.01* 
Pharmacy technician filling 1.24 (0.89-1.76) 0.21 1.29 (0.39-4.10) 0.67 




Table 3: Filling of the prescription, number and significance of performed interventions and data on readmission. 
Fisher’s Exact Test was used for categorical variables, Kruskal-Wallis Test for continuous or discrete variables. a 0=day 
of discharge, * = statistically significant, IQR = Interquartile range, PI = Pharmaceutical intervention 





Number of PIs per patient, median [IQR] 2 [1, 3] 1 [0, 3] 0.10 
Number of PIs per medicine, median [IQR] 0.33 [0.17, 0.50] 0.17 [0.00, 0.44] 0.05 
Significance of performed interventions    
Clinical significance (any clinical benefit) 108 (59.0) 71 (42.0) <0.01* 
Economic significance (lower costs)  80 (43.8) 98 (58.0) <0.01*  
Organisational significance (lower effort)  60 (32.8) 47 (27.8) 0.35 




10.00 [5.00, 15.00] 0.51 
Contacts established for the PI, n (%)   0.04* 
Only pharmacist  104 (56.8)  95 (56.2)  
Hospital physician 25 (13.7) 10 (5.9)  
General practitioner 0 1 (0.6)  
Hospital caregiver 0 3 (1.8)   
Home care  1 (0.5)    2 (1.2)  
Patient / relative 52 (28.4) 57 (33.7)  
Other 1 (0.5) 1 (0.6)  



















Readmission rate a, n (%) 
within 7 days 
within 18 days 

















Job role of the person filling the prescription, n (%) 
Pharmacist 
Pharmacy technician 















Table 4: Pharmaceutical interventions (PIs) in the community pharmacy, documented and classified with 
categories C, D and F of pharmDISC [22]. n=152, 76 patients in each group. 
 
 Control group  
(183 PIs) 
Intervention 
group (169 PIs) 
C Cause of intervention, all, n (%)   
C1.1 No concordance with guidelines, only suboptimal therapy possible 0 0 
C1.2 Contraindication  3 (1.6) 0 
C1.3 Interaction 19 (10.4) 3 (1.8) 
C1.4 Drug not indicated 0 0 
C1.5 Duplication 4 (2.2)  1 (0.6)  
C1.6 Adverse effect 0 0 
C1.7 Missing patient documentation 0 0 
C2.1 Inappropriate dosage form/administration route 2 (1.1) 3 (1.8) 
C3.1 Underdose 0 0 
C3.2 Overdose      1 (0.5) 1 (0.6) 
C3.3 Inappropriate monitoring   1 (0.5) 0 
C3.4 Dose not adjusted to organ function 0 0 
C4.1 Inappropriate timing or frequency of administration   5 (2.7) 2 (1.2) 
C4.2 Inappropriate application                            0 1 (0.6) 
C4.3 Inappropriate therapy duration 36 (19.7) 57 (33.7)  
C5.1 Insufficient compliance  3 (1.6) 3 (1.8) 
C5.2 Insufficient knowledge 7 (3.8) 4 (2.4) 
C5.3 Concerns about the treatment 14 (7.7) 13 (7.7) 
C5.4 Financial burden  16 (8.7) 17 (10.1)  
C6.1 Prescribed drug not available  18 (9.8) 24 (14.2) 
C6.2 Error in medication process                         30 (16.4)  17 (10.1)  
C6.2a Error in substitution due to process 2 (1.1)  7 (4.1)   
C7.1 Incomplete/unclear prescription 13 (7.1)   9 (5.3)  
C7.2 Illegible prescription 0 0 
C7.3 Missing prescription of necessary application aids 6 (3.3) 5 (3.0)  
C7.4 Formal/regulatory reason 3 (1.6) 2 (1.2) 





D1 Substitution 52 (28.4) 52 (30.8)  
D2 Dose adjustment 4 (2.2)  1 (0.6)  
D3 Adjustment of package size/quantity 40 (21.9) 66 (39.1) 
D4 Optimisation of administration/route 12 (6.6) 4 (2.4)  
D5 Therapy stopped/no delivery 9 (4.9) 2 (1.2)  
D6 Therapy started/continued 6 (3.3) 13 (7.7) 
D7 In-depth counselling of patient 10 (5.5) 4 (2.4)  
D8 Application instruction (training)  1 (0.5) 8 (4.7)  
D9 Delivery of compliance aid incl. counselling 4 (2.2) 2 (1.2) 
D10 Clarification/addition of information  42 (23.0) 17 (10.1)  
D11 Transmission of information 0 0 
D12 Proposition of therapy monitoring  3 (1.6) 0 
F Accepted and implemented interventions, n (%) 182 (99.5)  163 (96.4)  
